Inhibition of Akt/protein Kinase B Activity Sensitizes Moderately- to Un-Differentiated Gastric Cancer Cells to Chemotherapy.
Yao G. Wu,Xi Ming Xu,Gang Yuan,Jun H. Li,Zhong-Yan Zhou,Wei Ge
2007-01-01
Abstract:G cancer is the most common malignant tumor of the digestive tract in China. Development of resistance to chemotherapy also occurs frequently in tumor cells. Akt, also known as protein kinase B (PKB), is a 60kD serine/threonine kinase and functions downstream of phosphatidylinositol 3-kinase (PI-3K), controlling diverse cellular functions, including cell apoptosis, proliferation, differentiation, and glucose metabolism.1 In the present study, we studied the activities of Akt/PKB in gastric cell lines with different differentiation degrees (MKN-28, well-differentiated; SGC-7901, moderately-differentiated; BGC-823, poorly-differentiated; HGC-27, undifferentiated), and explored the effects of Akt/PKB inhibition on cell survival rates and apoptosis rates with treatment of etoposide. Cell culture. The current study was conducted between September 2005 and June 2006. The MKN-28 (well-differentiated), SGC-7901 (well-differentiated), BGC-823 (poorly-differentiated), and HGC-27 (undifferentiated) cells were cultured in RPMI1640 medium supplemented with 10% fetal bovine serum, 100U/ml streptomycin, 100U/ml penicillin in a humidified 5% CO2 atmosphere at 37 oC. The cells were digested with 0.25% trypsin and 0.02% EDTA every 2-3 days, and passed at ratio of 1:3-1:5. Cell survival rate assay. The 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyl tetrazolium bromide colorimetric assay was used to determine the cell survival rate. Gastric cancer cells in the logarithmic phase were seeded in 96-well plates, and treated with 20μmol/L etoposide in the presence or absence of a 2 hour pretreatment of 40nmol/L wortmannin for 0 hours, 3 hours, 6 hours, 12 hours, and 24 hours. Cell survival rates were assayed at the above time points. When exposed to 20μmol/L etoposide within 24 hours, the 4 gastric cancer cell lines exhibited time-dependent inhibition of cell survival rates. Pretreatment with wortmannin potentiated the inhibitory effect of etoposide on cell survival rates in a time-dependent manner. Except for MKN-28, there was a significant decrease in cell survival rates in other cell lines with pretreatment of wortmannin compared to without (p<0.01). Measurement of cell apoptosis rate. Cell apoptosis rate was determined with flow cytometry using double staining of annexin V and propidium iodide (PI). Gastric cancer cells were treated with 20μmol/L etoposide in the presence or absence of 2 hour pretreatment of 40nmol/L wortmannin for 0 hours, 3 hours, 6 hours, 12 hours, and 24 hours, followed by washing 2 times with 0.01mmol/L phosphate buffer solution. The cells were suspended with binding buffer and adjusted to a density of 1x106/ml. Cell suspension (1 ml) was centrifuged at 200g for 5 minutes. The supernatant was then discarded. Cell pellets were resuspended in 80μl binding buffer, and incubated with 10μl annexin-V-fluorescein and 10μl PI solutions at room temperature in the dark for 10 minutes. After centrifugation and resuspension in binding buffer, the samples were analyzed by flow cytometry with excitation wavelength of 488nm. When treated with 20μmol/L etoposide within 24 hours, the 4 gastric cancer cell lines showed time-dependent elevation of cell apoptosis rates. Pretreatment with wortmannin enhanced the effect of etoposide on cell apoptosis rates in a time-dependent manner. The cell apoptosis rates were significantly increased in SGC-7901, BGC823m and HGC-27 with pretreatment of wortmannin compared to without (p<0.01). Determination of Akt/PKB activity. The Akt/PKB activity was determined using a non-radioactive protein kinase assay kit. Basal PKB activity was measured as follows. Gastric cancer cells in the logarithmic phase were digested, and total protein was extracted from the cell lysates. The total protein was then incubated with immobilized antibody specific for phosphoAkt/PKB to immunoprecipitate Akt/PKB. The latter was used to phosphorylate a specific substrate, GSK-3 fusion protein (GSK-3α/β). Phospho-GSK-3α/β was analyzed by western blot with its monoclonal antibody. Enhanced chemiluminescence (ECL) was used to detect phosphoGSK-3α/β, which indirectly reflects the activity of Akt/PKB. The Akt/PKB activities in gastric cancer cells treated with etoposide for 0 hours, 3 hours, 6 hours, 12 hours, and 24 hours were also measured with the above method. Non-radioactive protein kinase assay revealed that the basal activities of Akt/PKB in these cancer cell lines are in the contrary order of differentiation degrees, MKN-28 < SGC-7901 < BGC-823 < HGC-27. Treatment with 20μmol/L etoposide led to time-dependent induction in Akt/PKB activities within 24 hours in the 4 cancer cell lines. The Akt/PKB activity was undetectable in cell lines pretreated with wortmannin. Discussion. Gastric cancer is the most common malignant tumor of the digestive tract in China, Brief Communication